Send the following on WhatsApp
Continue to ChatDeferasirox effectively reduces iron overload in non-transfusion-dependent thalassemia (NTDT) patients: 1-year extension results from the THALASSA study - https://avesis.istanbul.edu.tr/yayin/bebb85fc-b239-4e08-992e-e55822677861/deferasirox-effectively-reduces-iron-overload-in-non-transfusion-dependent-thalassemia-ntdt-patients-1-year-extension-results-from-the-thalassa-study